These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27155335)

  • 1. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
    Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
    Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14.
    Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S
    Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
    Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
    Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the PI3K-Akt pathway suppresses sFlt1 expression in human placental hypoxia models in vitro.
    Park JK; Jeong JW; Kang MY; Baek JC; Shin JK; Lee SA; Choi WS; Lee JH; Paik WY
    Placenta; 2010 Jul; 31(7):621-9. PubMed ID: 20488538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia.
    Li H; Yao J; Chang X; Wu J; Duan T; Wang K
    Reproduction; 2018 Mar; 155(3):297-306. PubMed ID: 29363569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1.
    Cudmore MJ; Ahmad S; Sissaoui S; Ramma W; Ma B; Fujisawa T; Al-Ani B; Wang K; Cai M; Crispi F; Hewett PW; Gratacós E; Egginton S; Ahmed A
    Eur Heart J; 2012 May; 33(9):1150-8. PubMed ID: 21411816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of TACC3 inhibits trophoblast cell migration and invasion through the PI3K/Akt signaling pathway.
    Zhu X; Cao Q; Li X; Wang Z
    Mol Med Rep; 2016 Oct; 14(4):3437-42. PubMed ID: 27572091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD97 Is Decreased in Preeclamptic Placentas and Promotes Human Trophoblast Invasion Through PI3K/Akt/mTOR Signaling Pathway.
    Shen H; Jin M; Gu S; Wu Y; Yang M; Hua X
    Reprod Sci; 2020 Aug; 27(8):1553-1561. PubMed ID: 32430705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production.
    Kaitu'u-Lino TJ; Tuohey L; Ye L; Palmer K; Skubisz M; Tong S
    Placenta; 2013 Feb; 34(2):168-73. PubMed ID: 23261267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of receptor tyrosine kinase-like orphan receptor 1 in preeclampsia placenta inhibits human trophoblast cell proliferation, migration, and invasion by PI3K/AKT/mTOR pathway accommodation.
    Chen J; Yue C; Xu J; Zhan Y; Zhao H; Li Y; Ye Y
    Placenta; 2019 Jul; 82():17-24. PubMed ID: 31174622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.
    Hastie R; Ye L; Hannan NJ; Brownfoot FC; Cannon P; Nguyen V; Tong S; Kaitu'u-Lino TJ
    Pregnancy Hypertens; 2018 Oct; 14():125-130. PubMed ID: 30527099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.
    Kaitu'u-Lino TJ; Palmer KR; Whitehead CL; Williams E; Lappas M; Tong S
    Am J Pathol; 2012 Mar; 180(3):888-894. PubMed ID: 22296769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromodomain protein BRD4 is increased in human placentas from women with early-onset preeclampsia.
    Liong S; Barker G; Lappas M
    Reproduction; 2018 Jun; 155(6):573-582. PubMed ID: 29748248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulated miR-149-5p contributes to preeclampsia via modulating endoglin expression.
    Xiaobo 赵肖波 Z; Qizhi H; Zhiping W; Tao D
    Pregnancy Hypertens; 2019 Jan; 15():201-208. PubMed ID: 30713088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ
    Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.